Transdermal Peptide TD-1 Amide
Transdermal Peptide TD-1 Amide
Product description
Transdermal Peptide TD-1 Amide is novel peptide designed to enhance transdermal drug delivery. Mechanistic studies suggest that the peptide creates transient opening in the skin barrier, which enables protein-sized molecules to pass through the skin and reach systemic circulation. When TD-1 is co-administrated with insulin on rat skin, systemic levels of insulin and human growth hormone are increased significantly.
Appearance | N/A |
---|---|
Molecular weight | N/A |
Purity | >90% |
Solubility | N/A |
Sequence | H-Ala-Cys-Ser-Ser-Ser-Pro-Ser-Lys-His-Cys-Gly-NH2 (disulfide bridge) |
One letter sequence | ACSSSPSKHCG-NH2 (disulfide bridge) |
Molecular Formula | C40H67N15O15S2 |
Storage | -20℃,protected from light and moisture |
Transportation | 4-25℃ temperature for up to 2 weeks |
Stability | 1 year |
Document
Related Product